Showing all published months. Partner preview tables include up to 20 countries.
USD value by month, all available partner countries combined
Free partner preview shows up to 20 countries.
Total value across the selected data period
| Partner | Value | Share |
|---|---|---|
| United States | $405M | 30.7% |
| Netherlands | $156M | 11.8% |
| Russia | $66.8M | 5.1% |
| United Kingdom | $52.5M | 4.0% |
| Thailand | $51.6M | 3.9% |
| Austria | $47.4M | 3.6% |
| Germany | $47.4M | 3.6% |
| Spain | $39.6M | 3.0% |
| Australia | $36.8M | 2.8% |
| Philippines | $30.8M | 2.3% |
| Hong Kong | $30.3M | 2.3% |
| Canada | $29.8M | 2.3% |
| Pakistan | $23.8M | 1.8% |
| Belgium | $22.3M | 1.7% |
| Mexico | $19.7M | 1.5% |
| Bangladesh | $18.8M | 1.4% |
| Brazil | $18.1M | 1.4% |
| Malaysia | $16M | 1.2% |
| New Zealand | $14.6M | 1.1% |
| Ghana | $13.7M | 1.0% |
Availability is confirmed when the API response loads.
| Partner | Value | Share |
|---|---|---|
| United States | $7.3M | 28.1% |
| Netherlands | $3.4M | 12.9% |
| Russia | $1.5M | 5.6% |
| Spain | $1.4M | 5.4% |
| Thailand | $1.2M | 4.7% |
| Germany | $879.2K | 3.4% |
| United Kingdom | $831.8K | 3.2% |
| Hong Kong | $821K | 3.2% |
| Australia | $711.3K | 2.7% |
| Pakistan | $588K | 2.3% |
| Philippines | $587.3K | 2.3% |
| New Zealand | $490.8K | 1.9% |
| Canada | $401.2K | 1.5% |
| Belgium | $376.7K | 1.4% |
| Brazil | $337.5K | 1.3% |
| Bangladesh | $326.6K | 1.3% |
| Austria | $321.8K | 1.2% |
| Chile | $320.3K | 1.2% |
| Nigeria | $288.3K | 1.1% |
| Mexico | $281K | 1.1% |
| Year | Export value |
|---|---|
| 2021 | $188.5M |
| 2022 | $217.4M |
| 2023 | $205.6M |
| 2024 | $269.4M |
| 2025 | $254M |
| 2026 | $183.4M |
Public data shows up to 20 partner countries for this exact eight-digit customs code. Request all available partner-month rows in CSV or Excel.
HS 96020010 is also written 9602.00.10. Values are in USD; the public series does not report tonnes or kg. Product scope: Dosage forms made from worked unhardened gelatin, specifically designed to encase medicinal substances for oral delivery as empty or filled shells. The public page shows monthly export partner previews from official GACC customs statistics. Full partner-month rows are available through a scoped custom data request.
Source: China General Administration of Customs (GACC), cleaned and structured by China Data Portal.
Transformations: Values are presented as published by the source.
China Data Portal. "China Pharmaceutical capsules (HS 96020010) Export Data." https://chinadata.live/china-trade/hs8/96020010/
HS 96020010 is also written 9602.00.10. Values are in USD; the public series does not report tonnes or kg. Product scope: Dosage forms made from worked unhardened gelatin, specifically designed to encase medicinal substances for oral delivery as empty or filled shells. The public page shows monthly export partner previews from official GACC customs statistics. Full partner-month rows are available through a scoped custom data request.
Source: China General Administration of Customs (GACC), cleaned and structured by China Data Portal.
Transformations: Values are presented as published by the source.
China Data Portal. "China Pharmaceutical capsules (HS 96020010) Export Data." https://chinadata.live/china-trade/hs8/96020010/
China exported $293M of pharmaceutical capsules in the twelve months to July 2026, averaging $24.4M per month, based on official China customs statistics (HS 96020010).
Dosage forms made from worked unhardened gelatin, specifically designed to encase medicinal substances for oral delivery as empty or filled shells.
United States, Netherlands and Russia together account for 48% of the published total, out of 79 trading partners on record.
Annual exports grew by 35% between 2021 and 2025, from $188M to $254M.
Figures come from official China General Administration of Customs (GACC) statistics, published monthly. ChinaData cleans partner names, periods and values so the series is ready for analysis. Partner-level rows for every month, including HS8 detail, are available on request.